Effects of Red Blood Cell Transfusion on Patients Undergoing Cardiac Surgery in Queensland—A Retrospective Cohort Study

Dhanapathy V, Obonyo N, White N, Sela D, Rachakonda R, Tunbridge M, Sim B, Teo D, Hoe LS, Fanning J, Tung J, Suen J, Fraser J Heart Lung Circul DOI 10.1016/j.hlc.2023.06.458

Background: Packed red blood cell (pRBC) transfusion is a mainstay in cardiac surgery, however, there is limited evidence on clinical effects of transfusing blood nearing end-of shelf life. This study aimed to investigate associations between morbidity/mortality and transfusion of blood near end of shelf-life (>35 days) in cardiac surgical patients.

Previous
Previous

Current animal models of extracorporeal cardiopulmonary resuscitation: A scoping review

Next
Next

A Novel Speckle-Tracking Echocardiographic Parameter Assessing Left Ventricular Loading During VA ECMO in a Pre-clinical Model of Cardiogenic Shock